These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35961417)

  • 41. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
    Liu J; Liu T; Pan J; Liu S; Lu GQM
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
    Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
    Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Mesoporous Silica Nanocarriers in Oncology.
    Baeza A; Vallet-Regi M
    Curr Drug Targets; 2018 Feb; 19(3):213-224. PubMed ID: 27262488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems.
    Wen J; Yang K; Liu F; Li H; Xu Y; Sun S
    Chem Soc Rev; 2017 Oct; 46(19):6024-6045. PubMed ID: 28848978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
    Baeza A; Manzano M; Colilla M; Vallet-Regí M
    Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
    Tran VA; Vo VG; Shim K; Lee SW; An SSA
    Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesoporous silica nanoparticles in nanotechnology.
    Douroumis D; Onyesom I; Maniruzzaman M; Mitchell J
    Crit Rev Biotechnol; 2013 Sep; 33(3):229-45. PubMed ID: 22724458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and Controllability of Mesoporous Silica Nanoparticles.
    Yamamoto E; Kuroda K
    Enzymes; 2018; 44():1-10. PubMed ID: 30360809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
    Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
    Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
    Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
    Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer.
    Castillo RR; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2017 Feb; 14(2):229-243. PubMed ID: 27402029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy.
    Li Y; Deng G; Hu X; Li C; Wang X; Zhu Q; Zheng K; Xiong W; Wu H
    Nanomedicine (Lond); 2022 Aug; 17(18):1253-1279. PubMed ID: 36250937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics.
    Cheng Y; Jiao X; Fan W; Yang Z; Wen Y; Chen X
    Biomaterials; 2020 Oct; 256():120191. PubMed ID: 32593907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
    Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesoporous silica nanoparticles in medicine--recent advances.
    Mamaeva V; Sahlgren C; Lindén M
    Adv Drug Deliv Rev; 2013 May; 65(5):689-702. PubMed ID: 22921598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.